The strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assurance that the strategic review of Novartis India will be completed in 2024, or that the outcome would result in the implementation of any transaction.
from Stocks-Markets-Economic Times https://ift.tt/ZNRJ1Fd
Novartis puts its India-listed entity for up for sale
Related Posts:
Rajan: Allow promoters to renegotiate under IBC- Stocks in the news: RIL, HDFC, Bharti Airtel, YES Bank, InterGlobe Aviation, TVS Motor and SpiceJet
- SGX Nifty down 20 points; here's what changed for market while you were sleeping
- Board Meetings Today: HDFC, RIL, Dabur India, Laurus Labs and Max Financial
- Rs 2.9k crore loan: Yes Bank to take over HQ of Anil Ambani
0 Comments:
Post a Comment